For over 70 years Electroconvulsive Therapy (ECT) has been used to treat severe depression and there are reports that it could help patients with Huntington’s Disease who experience psychiatric symptoms. Many patients with Huntington’s Disease experience depression, with suicide rates 5 to 10 times higher than the general public. In 21 published case reports where -
NYS Entity Status
NYS Filing Date
AUGUST 26, 2013
NYS DOS ID#
NYS Entity Type
DOMESTIC PROFESSIONAL CORPORATION
2013 - LUMSDEN PHYSICAL THERAPY, P.C.
Around the Web
- Does Electroconvulsive Therapy Improve Huntington’s Disease?
Wednesday Jul 19, 2017
- Sonic Forces is out for Switch, PS4, Xbox One and PC on November 7
By Mike Minotti - Thursday Aug 31, 2017
Sega announced today that Sonic Forces is coming out for PlayStation 4, Xbox One, Switch, and PC on November 7. Sega also revealed a special physical version of the game that will cost $40 and come with a controller skin and in-game character costumes based on some of Sega and Atlus‘s most famous stars (including […]
- Bots are becoming highly skilled assistants in physical therapy
By Michal Prywata, Bionik Laboratories - Sunday Oct 15, 2017
GUEST: Within the last decade, we’ve seen incredible progress in the fields of robotics and artificial intelligence. Innovators have been seeking out ways to meld man and machine and, in some areas, remove man altogether. In robotics, we’re seeing delivery drones, security robots, and more. In AI, chatbots, self-driving cars, and voice recognition have all made […]
- MSH3 Gene Reveals Critical Link With Huntington’s Disease
Wednesday Aug 9, 2017
A recent study published in Lancet Neurology reveals important associations between MSH3 gene mutations and Huntington’s disease progression and disease burden.
- The Link Between Huntington’s Disease and Brain Structure
Wednesday Sep 6, 2017
Scientists at Northwestern University have discovered a link between Huntington’s Disease and dysfunction of the brain’s structure. These finding may explain the causes of the debilitating symptoms and loss of brain tissue as the disease progresses. Currently, it is not understood why the mutation of a specific gene leads to expression of symptoms and loss -